ORGN 303-Ionic liquid "Therapeutic Agents": New paradigm in drug development

被引：0
|
作者：
Malhotra, Sanjay V. [1 ]
Kumar, Vineet [1 ]
Parchment, Ralph E. [2 ]
Jia, Lee [3 ]
Noker, Patricia E. [4 ]
Misra, Raj N. [3 ]
Narayanan, Ven L. [3 ]
Tomaszewski, Joseph E. [3 ]
机构：
[1] NCI, Lab Synthet Chem, SAIC Frederick, Frederick, MD 21702 USA
[2] NCI, Lab Human Toxicol & Pharmacol, SAIC Frederick, Frederick, MD 21702 USA
[3] NCI, Dev Therapeut Program, Bethesda, MD 20852 USA
[4] So Res Inst, Birmingham, AL 35205 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2008年 / 236卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
303-ORGN
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Cancer drug development in Europe: A selection of new agents under development at the European Drug Development Network
    Lacombe, D
    Butler-Smith, A
    Therasse, P
    Fumoleau, P
    Burtles, S
    Calvert, H
    Marsoni, S
    Sessa, C
    Verweij, J
    CANCER INVESTIGATION, 2003, 21 (01) : 137 - 147
  • [42] Gene expression microarray technologies in the development of new therapeutic agents
    Clarke, PA
    te Poele, R
    Workman, P
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (17) : 2560 - 2591
  • [43] ORGN 352-On the merge of fungal activity with ionic liquids toward the development of new biotechnological processes
    Pereira, Cristina Silva
    Rebelo, Luis Paulo N.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [44] The curious stories of drugs with two lives: a new paradigm in drug development
    MacPherson, Ross
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2015, 108 (07) : 255 - 258
  • [45] Changing the drug development and therapeutic paradigm with biologic drug combinations and bispecifics: How to choose between these two approaches?
    Zheng, Songmao
    Prell, Rodney
    Sheng, Jennifer
    Wang, Yow-Ming
    Hamuro, Lora
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (09): : 2096 - 2104
  • [46] Implementing precision medicine initiatives in the clinic: a new paradigm in drug development
    Hollebecque, Antoine
    Massard, Christophe
    Soria, Jean-Charles
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (03) : 340 - 346
  • [47] Oncology drug development: A new paradigm for managing clinical trials.
    Kovacevic, M
    Odeleye, OE
    Torchio, CR
    Nichols, W
    BLOOD, 1999, 94 (10) : 424B - 424B
  • [48] Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease
    Athar, Teeba
    Al Balushi, K.
    Khan, Shah Alam
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (07) : 5629 - 5645
  • [49] Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
    Teeba Athar
    K. Al Balushi
    Shah Alam Khan
    Molecular Biology Reports, 2021, 48 : 5629 - 5645
  • [50] Therapeutic drug monitoring of 8 new anticancer agents by high-performance liquid chromatography-tandem mass spectrometry
    Duretz, B.
    Gana, I
    Andriamanana, I
    Hulin, A.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 546 - 546
12345